Home
    Disclaimer
    πŸ§ͺ This is a research chemical with limited data on its long-term health effects, toxicity profile, and safe dosage ranges.

    Summary TheDrug.Wiki TripSit

    4-MeO-MiPT (4-methoxy-N-methyl-N-isopropyltryptamine) is a rare synthetic psychedelic first reported by Alexander Shulgin (TiHKAL #39). User reports describe a relatively gentle, tactile, and mood-enhancing experience with mild visual effects and a shorter duration than related tryptamines. Recent pharmacological research reveals 4-MeO-MiPT exhibits potent serotonin reuptake inhibition (SSRI activity, IC50 = 57 nM) alongside 5-HT2A and 5-HT1A receptor agonism, which may account for its atypical psychedelic profile characterized by reduced classical psychedelic effects compared to 4-HO-MiPT and 4-AcO-MiPT.

    Perspectives

    “This substance isn't particularly exciting or interesting, just a novelty. I had low expectations for it and they were barely even met.”

    “In 30–40 minutes, I found I could get some distortions of objects around me, if I really tried hard. There are no color changes. It is unexpectedly mild, and I have no anxiety, no tachycardia. At the two hour point, the peak must be past, and I feel somehow disappointed. I am not sure, in retrospect, if there was ever anything there at all.”

    Dose Information TheDrug.Wiki TripSit

    ROA Light Common Strong Heavy
    Oral 10mg 10-20mg 20mg 20mg+
    Light Common Strong Heavy

    Onset, Duration & After-effects TheDrug.Wiki TripSit

    ROA Onset Comeup Peak Offset After Effects Total
    Oral 15-45 min 30-60 min 1-2 hrs 1-2 hrs 1-3 hrs 2.8-5.8 hrs
    Insufflated 5-15 min 15-30 min 1-2 hrs 1-2 hrs 1-3 hrs 2.3-4.8 hrs

    Effect Profile

    7 reports

    Scores (1–10) curated from multiple sources:

    • Effect keyword matching from PsychonautWiki catalog
    • Weighted by importance: core (×3), major (×2), minor (×1)

    Full methodology

    Psychedelic 3.8
    Moderate 4/10

    Strong auditory effects with moderate body load, mild visuals, low headspace

    Visual Intensity ×3
    5
    tracers drifting brightened colour
    Headspace Depth ×3
    1
    confusion
    Auditory Effects ×1
    8
    auditory enhancement auditory distortion
    Body Load / Somatic Effects ×1
    6
    muscle tension bruxism jaw tension sweating

    Tolerance

    Build-up develops rapidly after a single use (serotonergic psychedelic)
    Reset 7–14 days for baseline

    Tolerance Decay

    Full tolerance 1d Half tolerance 3d Baseline ~10d

    Rapid tolerance like other 5‑HT2A psychedelics; spacing sessions by 10–14 days helps restore baseline sensitivity. Evidence level: anecdotal/user‑report across tryptamines; no pharmacokinetic studies for 4‑MeO‑MiPT.

    Effects Erowid

    Aggregated from 7 Erowid experience reports

    Positive Effects 7

    Empathy 85.7% 70%
    Color Enhancement 85.7% 70%
    Music Enhancement 71.4% 70%
    Euphoria 57.1% 70%
    Focus Enhancement 57.1% 70%
    Stimulation 42.9% 70%
    Body High 42.9% 70%

    Adverse Effects 2

    Anxiety 42.9% 70%
    Muscle Tension 42.9% 70%

    Combinations TripSit

    Trip Reports Effect Index

    PiHKAL / TiHKAL Shulgin

    TiHKAL #39: 4-MeO-MIPT

    “In 30–40 minutes, I found I could get some distortions of objects around me, if I really tried hard. There are no color changes. It is unexpectedly mild, and I have no anxiety, no tachycardia. At the two hour point, the peak must be past, and I feel somehow disappointed. I am not sure, in retrospect, if there was ever anything there at all.”

    β€” Alexander Shulgin, TiHKAL (with 10 mg, orally)

    Helpful Links